Proximal Ventures captured $27.5 million for its first fund and has already backed seven startups that use artificial intelligence in life sciences. Its founder, Sahir Raoof, is betting that technology automates pharmaceutical services that today require time and high costs, although the thesis still depends on converting technical capabilities into tools that industry adopts.